NCT03615781

Brief Summary

The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allowing up to 3 surgical lavages and allocating patients into a two-week's and a four week's randomization arm

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

January 16, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 6, 2018

Completed
Last Updated

August 6, 2018

Status Verified

July 1, 2018

Enrollment Period

2.8 years

First QC Date

January 16, 2017

Last Update Submit

July 30, 2018

Conditions

Keywords

septic arthritissurgeryantibiotic durationremissionsequelae

Outcome Measures

Primary Outcomes (2)

  • Clinical Remission of systemic infection

    Measurement of fever.

    6 months

  • Sequels

    Patient's remaining gait disorders. * range of movement in adjacent joints of former infection * questionnaire regarding persistant pain and handicaps (open wording)

    6 months

Secondary Outcomes (3)

  • Wound redness

    6 months

  • Wound discharge

    6 months

  • Presence of pus

    6 months

Study Arms (4)

Two week's arm - surgery

EXPERIMENTAL

The investigators perform a surgical drainage and removal of the infected orthopedic implant.

Procedure: Two week's arm - surgery

Four week's arm - surgery

ACTIVE COMPARATOR

The investigators surgically remove the infected implant.

Procedure: Four week's arm - surgery

Two week's arm - drugs

EXPERIMENTAL

The investigators perform a surgical drainage and removal of the infected orthopedic implant. They start an empirical antibiotic treatment based on patient's history and co-morbidities, such as vancomycin or amoxicillin/clavulanic acid. The adapt later on the targeted antibiotic therapy according to the causative pathogens and their antibiotic susceptibility testing.

Drug: Two week's arm - drugs

Four week's arm - drugs

ACTIVE COMPARATOR

The investigators surgically remove the infected implant and all soft tissue infection. Instead of a total of 2 week's of antibiotic therapy, they administer a total of 4 weeks of systemic antibiotic therapy targeted to the pathogen(s).

Drug: Four week's arm - drugs

Interventions

The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant.

Two week's arm - surgery

The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant.

Four week's arm - surgery

After the surgical implant removal, the investigators prescribe a total of 2 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously.

Two week's arm - drugs

After the surgical implant removal, the investigators prescribe a total of 4 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously.

Four week's arm - drugs

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>17 years
  • Microbiologically-confirmed septic arthritis
  • At least one surgical drainage/lavage

You may not qualify if:

  • Presence of osteosynthesis material in the vicinity of the articulation
  • Presence of a concomitant infection needing more than 2 week's of antibiotic therapy
  • More than 3 surgical drainages
  • Life expectancy less than 6 months
  • Chronic osteomyelitis in vicinity of the arthritis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geneva University Hospitals

Geneva, 1211, Switzerland

Location

Related Publications (2)

  • Uckay I, Tovmirzaeva L, Garbino J, Rohner P, Tahintzi P, Suva D, Assal M, Hoffmeyer P, Bernard L, Lew D. Short parenteral antibiotic treatment for adult septic arthritis after successful drainage. Int J Infect Dis. 2013 Mar;17(3):e199-205. doi: 10.1016/j.ijid.2011.12.019. Epub 2012 Nov 22.

    PMID: 23183231BACKGROUND
  • Gjika E, Beaulieu JY, Vakalopoulos K, Gauthier M, Bouvet C, Gonzalez A, Morello V, Steiger C, Hirsiger S, Lipsky BA, Uckay I. Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial. Ann Rheum Dis. 2019 Aug;78(8):1114-1121. doi: 10.1136/annrheumdis-2019-215116. Epub 2019 Apr 16.

MeSH Terms

Conditions

Arthritis, Infectious

Condition Hierarchy (Ancestors)

InfectionsArthritisJoint DiseasesMusculoskeletal Diseases

Study Officials

  • Ilker Uçkay, MD

    University Hospital, Geneva

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending, Docent Dr. med Ilker Uçkay

Study Record Dates

First Submitted

January 16, 2017

First Posted

August 6, 2018

Study Start

June 1, 2015

Primary Completion

April 1, 2018

Study Completion

May 18, 2018

Last Updated

August 6, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations